# On Demand Treatment of Reflux Disease

> **NCT00184522** · PHASE4 · COMPLETED · sponsor: **Norwegian University of Science and Technology** · enrollment: 82 (actual)

## Conditions studied

- Gastroesophageal Reflux

## Interventions

- **DRUG:** Aflurax
- **DRUG:** esomeprazole

## Key facts

- **NCT ID:** NCT00184522
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2004-11
- **Final completion:** 2004-12
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2011-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00184522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00184522, "On Demand Treatment of Reflux Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00184522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*